Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for the analysis swing_trader! member mark for you!
One question if you have the time: where do you see the next breakout taking us?
TIA.
oh yeh - nefariousness never happens in the business world! hehe!
It is much easier to believe that John has somehow managed to dupe the following:
MGMT: CFO from NASDAQ: NSIT, CEO from NYSE: RKT, COO from NYSE: RKT
FUEL: NYSE: X, XTR Energy, NYSE: OXY, Indigo Energy Partners, COCO Paving
Partners: NYSE: RKT, Madison County Department of Solid Waste and Sanitation
Investors: Billionaire Meyer Luskin, Trent Vichie & Michael Dorrell from NYSE: BX
Media: Discovery channel, National Public Radio, Local news
Validation: NYSE: SAI, Islechem of NYSE: OXY
Government: Mayor of Niagara Falls, 4 Senators
Indeed, John must be a genius!
yes, that is much easier to believe than the possibility that other businesses and individuals involved in the plastic business might have tried to do JBI harm.
right. everybody except john and jbi play fair!
got it, thanks.
you need not worry, its been paid.
yes, things were said to be on the horizon that never materialized -- i wouldnt say they were "promised" though.
i dont imagine it was in any way easy to execute on any plans with the SEC trying to sink you --- yes sink: initially they wanted 10 million in disgorgement and fines -- months before the suit was brought up, John and JBI tried several times to settle for more than the fines turned out to be -- The woman in charge at the time wouldnt have it -- so JBI was at a standstill while fighting the SEC over this.
Plans went by the wayside the moment that wells notice was issued. So i am sorry the plans that didnt materialize are so upsetting -- but plans are still unfolding -- and what they have achieved in a few short years in terms of engineering is impressive to me
---------------
here are three examples of fights JBI had to overcome to get to this point -- there are many more:
coventa has ties with current governor(at the time) and puts the kibosh on JBI getting their first permit. The next incoming governor(one more month before taking office) who has no previous ties with coventa to the rescue -- one conference call between him,NYDEC,and JBI - and poof, the permit is IN!
an sec employee recieves daily calls(negative reports) from a "concerned" investor about a company that just so happens to deal the the same product his does:plastic!. over many months a trust develops and the sec employee is nefariously fed many bogus details -- a nudge here and there and poof: a wells notice is born!
a campaign of incessant phone calls is launched at any entity that does business with jbi. eg: NYDEC recieved dozens a day -- one of which reported "plumes of smoke rising out of the JBI factory" -- just so happens that the NYDEC was at JBI that day, all day, testing the processor -- they certainly didnt see plumes of smoke! Some companies have chosen to sever ties with JBI due to such nefarious phone call campaigns.
its a miracle they survived if you ask me.
-a limp officer ban for a person who is no longer an officer anyway.
-a quarter of a million in fines pales in comparison to the touted millions(upwards of 10!) in disgorgement and fines -- doesnt it?
I call that great news, yes.
--------------------------------
i see a company that has had to fight tooth and nail against various nefarious(my opinion) onslaughts.
i see a company that almost had to fold in 2012 because they had to push all of their resources toward fighting the SEC and others in court.
How can a startup company with limited resources execute a business plan under these conditions? They couldnt. There were at a virtual stand still for quite some time -- the attacks almost succeeded.
-------------------------------
some see a company that is on its way to its low point.
I see a company that has had its low point and is now in the process of dusting itself off after multiple blows, preparing to fight again.
------------------------------
lets see who wins -- my money is on jbi
considering expenses continue to come down and revenues go up -- i think mine is a good bet.
sure those revs have not gone up as fast as i would like, and sure the expenses were way higher than i would like -- but considering the painful year of fights jbi has had and the resources it has had to expend to come out of those fights alive -- i dont think its as bad as its portrayed.
-------------
place your bets -- up or down....and GLTA
regen biopharma has up to 20 million in financing in place.
http://www.marketwire.com/press-release/bio-matrix-scientific-group-inc-announces-newly-formed-stem-cell-subsidiary-regen-biopharma-otcqb-bmsn-1650228.htm
no revenue? a startup biotech with no drugs on the market yet - is somehow suppose to have revs? really?
please point out one that does, because i would love to invest in that company!
I am sorry but i just dont think you are correct.
sorry, didnt mean to sound confrontational...
i would like to add that i am not even talking about actual available shortable shares -- i am talking about naked shorting.
naked shorting is what MM's do -- and since there is zero oversight -- they can do it as much as they want.
no way -- this is a trip to the triples... i just hope its a return ticket and not a one way. my 0.018s are looking pretty hopeless right now.
oh boy -- so the SEC signs off an a settlement.... but!! they have been somehow swindled into that by JB right..?
and now the judge signs off on the settlement... but!!! the judge and everyone else involved are rank amateurs who screwed it all up so ooopppps! the settlement doesnt count now!
They will have to do it all over again!
Really?
ummm...ya, right.
I will trust & believe the actual people involved in making this settlement a reality.... rather than.....you know....
thanks again Rupadupa for the insights.
got CIRC on my radar and will continue to evaluate.
GLTA
thank you CliffRaRaRa86, I will take that into consideration.
do you understand that that does not apply to a market maker? they can and do naked short, especially on the otc/pink where there is limited oversight by the sec.
they can also walk a price down quite easy by bid whacking in small blocks, like 5000 shares at atime. there is no trader that would sell a penny stock 5000 shares at a time or even 50000 shares at a time at the bid-- but the mm can constantly throw those kinds of share bloocks at the bid...
it doesnt matter how much buying pressure there is- no stock can withstand persistent bid whacking like that.
Edit** i forgot to point out: an mm can also bid whack its own bid over and over. an endless cycle of price manipulation.
even the strongest of bulls cannot fight a persistent and sustained bid whack.
Thank you Rupadupa for the report! Can I ask a couple more questions: Is there any consensus on when a settlement might take place? Could playboy filibuster CIRC into BK before any settlement?
I dont think PB has a chance in this case, they seem to be totally in the wrong - but with their money, my worry is they might just stall and stall....
potential investor with a couple questions.
i read that there were 3 favorable ruling previously. I am wondering:
-why werent any of those rulings the "catalyst" for new highs? Were all these cases started at the same time and thus the pps is waiting for all the rulings to complete?
-after this next (most likely) favorable ruling - can/will playboy just appeal/contest over and over?
thanks.
agreed -- bought in at .018! ouch!
IMO this will go to trips before it ever goes green for me...
It was painfully obvious when we were well above a penny that someone was diluting -- shares were continually dumped at the bid no matter how much buying pressure there was.
oh well -- win some, lose some.
GLTA
didnt know the SEC is handing out suspensions to companies that have 'similar charts' to other suspended companies. -- wow, that is a pretty strict policy. How can companies not yet afflicted with a similar chart, stave off having a similar chart as a bad company?
Any chart'ists out there with answers?
hope my other stocks dont develop similar charts -- wow!
Its blatantly obvious isnt it? I am convinced Q1 will be just shy of being CFP.
Many didnt think news would be out -- i believe the IND is on hold.
So?
The only absolute in OTC is that there are no absolutes. Dont need to be a pinkologist to figure that out.
--------------
To declare all companies on the OTC/pink are scams is severe folly in my opinion.
Numerous is the amount of OTC/pink companies that were able to grow there business plan, shrug off the shackles of the penny exchanges, and move on to the senior markets and success.
amgen is just one of many that traded for pennies and was no doubt declared a scam by "pinkologist's" of the time.
--------------
Regen biopharma expected to file the IND Q4 2012 -- well, plans dont always go according to plan. They didnt file until middle Q1 2013.
Sure it would be easy, back in december to say: "what a dilusion scam machine -- I told you they would never file the fairy-tale IND!!! ROTFL!!!"
Of course, we know now that would have been folly.....
I followed a company that was to receive a permit from the NYDEC to begin operations around a certain date --- that permit did not arrive for another 8 months! How many times during that 8 months did I read: "haha - i told you they would never get the permit - just a scam pinky!1 ROLFL!!!" --- i cant even count.
BMSN --with the help of Cromos Pharma -- filed the IND. Resulting news of the IND will arrive when its good and ready....Whether good or bad. And no, I do not believe the IND and subsequent approval for clinical trials are all just an elaborate ruse to sell more shares.
i am sorry: normal buying and selling is dumping?
seems like a normal trading day to me -- sometimes up, sometimes down.
and please define: "consultants". i am unaware of such "consultants". could you please inform the uninformed?
how much compensation were they give?
a link would be great, thanks friend!
boilerplate settlement terms.
I see nothing out of the ordinary -- please explain otherwise!
startups lose money until their product is fully matured -- its time to face up to that reality.
The only reason its become such a big deal with JBI is because they are one of the rare companies that chose to go through the process publicly rather than privately....
so what are YOU suggesting?
is it your contention that JBI is BUYING plastic from them?
if so, what is the price? give us some details then.....?
otherwise: balderdash
wow just wow....
where to start....
companies make plans for the future -- some plans dont work out -- that could hardly be considered lies. if it were then every company in existence should be considered liars.
startup venture capital -- its something millionaires and billionaires give to startup companies which they believe will be big -- i trust their judgement.
please provide links or proof of any kind that "hundreds or thousand of folks relied on lies" ----- asked many time -- never any proof.
I certainly didnt -- shall we take a poll?
i believe "Bordynuik" couldnt give a flying buck. He created something worth while and he knows it -- many live their whole lives wallowing in mediocrity and wallow even further in angst at their own shortcomings. "Bordynuik" doesnt.
IND means: Investigational New Drug --- Bmsn has a drug that they want to start testing on humans -- so they file an IND application with the FDA.
The FDA then reviews the application, most likely talks further to the company to get more information. Then when the FDA is satisfied that the company is ready and the drug is safe enough, they give the go-ahead to the company to start clinical trials.
FDA approval comes after the lengthy trials are complete. There are three phases to the trials and can/might/will take many years to complete.
The FDA reviews the results from the clinical trials and makes a determination on whether or not the company should be allowed to begin manufacture and sales of the new drug. If the FDA determines that the drug is ready for use by the general public, then it will give approval. If there were complications during clinical trials the FDA can deny approval for the drug and the company is back to square one.
There is one more wrinkle: The FDA can assign 'Orphan Drug Status' to certain drugs that are meant to treat rare diseases. BMSN/Regen's HemaXellerate I drug fits in with this designation because it is meant to treat 'aplastic anemia'.
Therefore: after IND approval for clinical trials, the FDA will again review another application by the company which will be for 'orphan drug status' -- regen biopharma has already indicated that it is their intention to seek this status after IND approval.
orphan drug status provides the company exclusive rights to the product for a number of years along with other financial and scientific 'bonuses' meant to help the company through clinical trials. This status will also reduce the time spent on phase 3 clinical trials due to the reduced number of patients that the drug need be tested on.
in my opinion: orphan drug status is a slam dunk.
biotech companies that have a drug in clincal trials have seen a huge boost to the share price after orphan drug status designation.
feel free to pm if you have more questions.
My SPECULATION:
IND application on hold for more information. It's BMSN's first IND - I think this should be expected.
They enlisted the help of Cromos pharma - they've had experience with IND's on hold -- this is great! Cromos is/will help expedite the process of fulfilling all requirements to get the clinical trials going.
I believe that it might add a few days or even a week to the whole IND process which is why we sit and wait rather than cheer the PR.
I would say that there is absolutely NO WAY the IND has been denied at this point, we should all rejoice in that!
The clinical trials will start when the IND is complete. Until then I check this database regularly for an HemaXellerate entry in the aplastic anemia trials area.
http://www.clinicaltrials.gov/ct2/results?term=aplastic+anemia&Search=Search
I think we all need to chill -- there are no absolutes when it comes to government agencies, especially when we are dealing with the health and safety of potential patients. if they want to take an extra week to get it right then they will -- they dont care about some arbitrary 30day rule -- they dont care that a bunch of hubbers are on pins and needles.
step away from the computer and breathe!
personally, I am now looking forward to the build up to orphan drug status...!
ok- the contention is that JBI has never produced one drop of fuel ever...really? wow. i cant even approach that with an answer.
next that jbi is a scam: hmmmm. the sec investigated jbi for 1.5 years!!!!!! think about that: 1.5years...! so jbi is a scam that is sooooo good that it was able to scam the sec for 1.5 years.... reallly?
wow! OMG!!! i just dont know how to respond to that
You cannot in any way prove that spec fuel is the direct result of only the use of a back end refinery and not a catlyst.
Again:
is it your contention:
-that JBI does not use any catalyst? That they are lying about the use of a catalyst?
-that the SAIC report is fake?
By "craft"
-- you contend:
-that JBI does not produce spec fuel from waste plastic?
-that JBI does not use any catalyst?
-that the SAIC report is fake?
Correct me if I am wrong: Is not the millions in venture capital that is pouring into JBI from prominent millionaires and billionaires being used to further develop business plans and technology? The fact that these investors are so willing to invest in JBI's future success suggests to me that they BELIEVE in JBI's future success.
You use of the word "profit" troubles me: Are you suggesting that JBI management is using that venture capital for their own benefit rather than the companies???
If so, then please do clarify!
very wrong:
1: catalyst was not revealed to the world, and thats what sets JBI apart from the "competition"
2: pyrolysis are similar -- the catalysts are not.
3: NOPE they cant. Name one company that produces spec fuels from waste plastic and selling to juggernauts like X besides JBI...
4: Again: spec fuel from waste plastic -- if thats not genius then I dont know what is...?
5: Again: catalyst....
6: SEC SAYS NO FRAUD AFTER 1.5 YEAR INVESTIGATION: ISSUES SMALL FINE TO JBI FOR ACCOUNTING ERROR. not sure why that is so hard to grasp..?
Spec fuel from waste plastic.
Millions in venture capital from prominent billionaires.
P2O is non-polluting to environment says NYDEC.
SAIC agrees JBI makes spec fuel at low price!
agylix: CANNOT produce anything near FUEL at a much higher cost and CANNOT SELL their "product" at anywhere near the price JBI gets for its ultra-clean spec fuel!
i guess definitions of embarrassing can vary greatly huh?
you still dont understand the concept of what a startup company entails do you...?
I wasnt aware that startups in the proof of concept stage of the product lifecycle are all cash flow positive...?
-JBI has millionaires and billionaires forking over millions in venture capital.
-NYDEC and SAIC says P2O is great as far as they are concerned.
ONE MORE TIME:
groundbreaking technology with blessings from NYDEC and SAIC and tons of venture capital pouring in from prominent billionaires.
The potential seems a tad great in favor of JBI over the paperboy...
how you could claim that they are 90% accurate is beyond me: i defy you to prove it!
these sites throw out one fantastic claim after another -- according to them every company is on the verge of being bought out by every other company. BMSN was suppose to be bought out weeks ago and the finishing touches on the FDA approval PR were being done the beginning of last week.... they throw darts. And truthfully, they are NOT very accurate.
ask yourself this: if they really had insider info as explosive as bmsn being bought out OR that phizer is teaming up with fledgling BMSN -- do you really think they would let everyone know about it...? If you answer yes, they ask yourself WHY? why would they do that? first off: I am sure they dabble in buying and selling shares of the companies they "report" on, so if they were anywhere near as accurate as claimed -- the SEC woulda came down on them like a hammer for insider trading.
My guess: those sites buy low -- release "confidential explosive info" -- sell as the price goes up a tad -- then short as the price inevitably falls due the fact that their so-called info was not real.
If they knew so much -- why didnt they "alert" us that BMSN was "Acquiring Issued US Patent Covering Cancer Gene-Silencing Technology" ???
There is a great chance that we will see a pr this week about FDA approval for go ahead with clinical trials - there was a good chance we were going to see it last week -- thats why they claimed the "PR was being drawn up" early last week -- they were throwing darts...making educated guesses.
What they do is no different than how a psychic employs techniques like cold call reading.....
Please, i am begging you -- give this adam and johnny thing a rest. THEY ARE AS CLUELESS AS THE REST OF US.
So what your trying to say is that the DEC is not doing its job properly in giving JBI permits to run its P2O process?
IF thats not what your driving at, then please clarify..?!
As a concerned citizen, perhaps you should call the DEC directly with your concerns. I am sure they would love to hear from you!
oh and please let us know how that call goes, thanks.
By fraud do you mean how:
The SEC investigated JBI for over 1.5 years and then issued a small fine for a simple accounting error because they could find nothing else to complain about
Thats not fraud friend. THATS AN ACCOUNTING ERROR.
Hello,
Please direct me to a chart that shows when JBII was ever below $0.50.. k, thanks.
Even at the most dire times of the SEC's debacle of an investigation into a simple accounting error did the price drop below $0.50.
wrong again.
How is JBI imploding?
By imploding do you mean how venture capital is pouring into JBI from prominent millionaires and billionaires?
-ah i know: by imploding you mean how JBI was investigated for 1.5 years by the SEC for an accounting error and how the SEC FOUND NOTHING ELSE TO COMPLAIN ABOUT EXCEPT A SIMPLE ACCOUNTING ERROR and thus issued a small fine????
-Or maybe you mean how JBI's P2O process has garnered mucho favorable reports from SAIC??
-Or how JBI makes spec fuel, not peanut butter?
-Or how the NYDEC has tested the heck outta the P2O processor and each time found ZERO environmental issues and has been extremely supportive and forthcoming with regards to permits?
I gotta admit, my definition of the word implode is slightly different...
LMAO!!! OMG!
I agree with you.
There is NO WAY some "nice ladies" at the FDA gabbed for 1 hour over the phone about the approval of the IND application for HemaXellerate before any official approval by the FDA or the company has been publicly disseminated.
However, there is a gray area in regards to shortened clinical trials for a drug with Orphan drug status.
The main function of Orphan Drug Status by the FDA is as follows: "The designation grants U.S. market exclusivity to a drug for a particular indication for a seven-year period if the sponsor complies with certain FDA specifications. Additional incentives for the sponsor include tax credits related to clinical trial expenses and a possible exemption from the FDA-user fee. The designation does not shorten the duration of the regulatory review and approval process."
I am unable to find any definitive data that states that its in the FDA mandate to shorten clinical trial timelines for a drug with orphan drug status.
HOWEVER: A drug that has ophan drug status is exempt from the following rule: "In Phase 3 trials, the treatment is given to large groups of people (1,000-3,000)". The FDA recognizes that - due to rarity of the disease that an orphan status drug is treating - it would be much harder to find 1000 or more test subjects. Exemption from this rule will dramatically shorten the phase 3 trial timeline since there are much fewer test subjects that need be tested on and far less data to be collected, analyzed, cataloged, etc.
So no, its not in FDA mandate to specifically shorten clinical trial timelines for a drug with orphan drug status.
But yes, CLINICAL TRIAL TIMELINES WILL BE SHORTENED, especially during phase 3 trials, due to exemption to the minimum test subject rule.
IMO: We have been approved for clinical trials OR are on hold for more information.
IMO: We will get orphan drug status.
IMO: There is no way that the FDA would prematurely release this kind of information to the general public over the phone until it has been officially stated.
GOOD GRAVY!!!
your right! JBI is probably producing for less than 10/BBL
OMG!
thanks for pointing that out kind sir!
OMG!
OMG!
a startup company that is in the process of maturing their product is losing money... OMG!!!!
startups are suppose to be cash flow positive from inception...right?!
OMG!!! this startup company has millionaire & billionaire investors..OMG!!!!
OMG!!! this startup company was investigated for over 1.5 years by the SEC for a simple accounting error...and...OMG!!! they didnt find anything else to complain about, so they settled for a small fine for the accounting error...!!!OMG!!!
OMG!!! venture capital from many influential individuals is pouring into JBI....OMG!!! JBI must be on the cusp of something great..OMG!!!
wow..just...wow -- this company is gunna rock!!!
OMG!
Let me ask you this: If, as is generally agreed upon to be true: the SEC were "breathing down JBI's neck" looking for something. anything....if that is the case -- would JBI really be fudging all the numbers as you allude? Really, you think they would...?
The SEC investigated JBI for 1.5 years -- many expected many more charges to follow the overblown accounting error affair... but alas, nothing..... The SEC found nothing else to complain about... only an accounting error.
So what is the truth here: that JBI has pulled the wool over the SEC's eyes while being investigated...OR...that the truth is much less fantastic, perhaps even banal in comparison -- that JBI is a small startup company using venture capital to tirelessly mature its product while simultaneously having to publically work through growing pains that most other companies do privately....?
I tend to believe the less fantastic of the two versions. John and JBI are not svengali's -- if they were really that good then there wouldnt have been the whole accounting error thingy to begin with.
It's time to stop believing this fanstastical fairy-tale and come to grips with reality: JBI is a startup company trying to succeed.
Boring I know....
How do you know any company is profitable?????
You read their financials. This is not rocket science. Any company could potentially fudge the numbers. Its up to each individual investor to decide what to make of those financials.
Your contention then is that: JBI, while being investigated by the SEC for ACCOUNTING PROBLEMS -- would decide to intentionally start "fudging the numbers" << really?
that is bold!